Influence of delayed CSF storage on concentrations of phospho-tau protein (181), total tau protein and beta-amyloid (1–42)

Tau and Aβ42 in Cerebrospinal Fluid from Healthy Adults 21–93 Years of Age: Establishment of Reference Values

Magnus Sjögren, Hugo Vanderstichele, Hans Ågren et al. · Clinical Chemistry · 2001 · 441 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Standardization of measurement of β-amyloid_(1-42)in cerebrospinal fluid and plasma

Hugo Vanderstichele, E Van Kerschaver, Camilla Hesse et al. · Amyloid · 2000 · 305 citations

Life Sciences, Neurology, Neuroscience +17

Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

Nancy C. Andreasen, Lennart Minthon, Eugeen Vanmechelen et al. · Neuroscience Letters · 1999 · 242 citations

Medicine, Neurology, Neuroscience +14

Effects of Processing and Storage Conditions on Amyloid β (1–42) and Tau Concentrations in Cerebrospinal Fluid: Implications for Use in Clinical Practice

Niki S.M. Schoonenboom, Cees Mulder, Hugo Vanderstichele et al. · Clinical Chemistry · 2004 · 162 citations · Full text

Life Sciences, Biochemistry, Neuroscience +14

Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer's disease

Peter Schönknecht, Johannes Pantel, Aoife Hunt et al. · Neuroscience Letters · 2003 · 63 citations

Life Sciences, Neurology, Neuroscience +17